BiotechTube
Scope Fluidics

Scope Fluidics

Warsaw, Poland· Est.
scopefluidics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $11M

Overview

Scope Fluidics is a publicly traded Polish biotech firm leveraging microfluidics to create rapid, point-of-care diagnostic solutions. The company has successfully developed and commercialized its PCR|ONE system through a sale to Bio-Rad and is now advancing its BACTEROMIC system for antimicrobial susceptibility testing. Its core strategy involves incubating innovative projects in separate subsidiaries before forming strategic partnerships or outright sales to large global diagnostics companies for commercialization.

Infectious Diseases

Technology Platform

Microfluidic technology for integrated, rapid diagnostic systems, encompassing chip design, prototyping (micro-machining/injection molding), assay integration, and instrumentation.

Funding History

3
Total raised:$11M
Grant$500K
Series A$8M
Seed$2.5M

Opportunities

The global antimicrobial resistance crisis creates a massive, growing demand for rapid AST solutions like BACTEROMIC.
The successful sale of PCR|ONE to Bio-Rad validates the technology and business model, providing capital and credibility to pursue further partnerships in the large, innovation-hungry in-vitro diagnostics market.

Risk Factors

Key risks include technical failure or delays in the BACTEROMIC development, inability to secure a favorable partnership or exit for the technology, and cash burn exceeding runway before reaching a value inflection point.
The company also faces intense competition from large diagnostics firms and other startups.

Competitive Landscape

Scope Fluidics competes in the rapid diagnostics and AST space against large, established players like bioMérieux, Becton Dickinson, and Danaher (through Cepheid), as well as numerous agile startups. Its differentiation lies in its focused microfluidic expertise and its unique asset-light, partnership-driven business model.

More companies in Diagnostics & Precision Medicine →More companies in Poland →